Published in J Exp Med on October 01, 1995
Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69
Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. J Biol Chem (2002) 1.73
Does nitric oxide play a critical role in viral infections? J Virol (1998) 1.62
Human macrophages support persistent transcription from unintegrated HIV-1 DNA. Virology (2007) 1.46
HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. J Neurochem (2006) 1.31
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev (1996) 1.13
Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J Virol (2002) 1.00
Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS. Retrovirology (2014) 0.99
Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS. Mol Med (1999) 0.94
Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia (2014) 0.91
Methamphetamine abuse, HIV infection, and neurotoxicity. Int J Physiol Pathophysiol Pharmacol (2009) 0.87
Antioxidant protection from HIV-1 gp120-induced neuroglial toxicity. J Neuroinflammation (2004) 0.83
HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes. J Clin Invest (1998) 0.83
Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. Proc Natl Acad Sci U S A (1998) 0.82
Effect of nitric oxide on poliovirus infection of two human cell lines. J Virol (1998) 0.80
Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2. Clin Diagn Lab Immunol (2000) 0.80
Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor. J Clin Invest (1997) 0.79
Critical role of nitric oxide during the apoptosis of peripheral blood leukocytes from patients with AIDS. Mol Med (1999) 0.77
Production, regulation and role of nitric oxide in glial cells. Mediators Inflamm (1998) 0.77
Screening assay for oxidative stress in a feline astrocyte cell line, G355-5. J Vis Exp (2011) 0.77
In vitro activation of feline immunodeficiency virus in ramified microglial cells from asymptomatically infected cats. J Virol (2001) 0.76
Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system. Cell Mol Neurobiol (2000) 0.75
HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation. J Neurosci (2017) 0.75
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24
Synthesis of nitric oxide in CNS glial cells. Trends Neurosci (1993) 2.81
Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science (1990) 2.74
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol (1993) 2.53
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology (1994) 1.80
Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4. J Virol (1992) 1.66
Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commun (1992) 1.50
Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol (1993) 1.48
Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience (1994) 1.36
Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol (1991) 1.34
Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol (1992) 1.32
Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol (1991) 1.26
Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol (1992) 1.19
Human immunodeficiency virus infection in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol (1992) 1.14
Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol (1992) 1.08
Productive infection of human fetal microglia by HIV-1. Am J Pathol (1993) 1.07
gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol (1994) 1.04
Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res Hum Retroviruses (1991) 1.04
Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev Neurosci (1991) 0.98
Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci Lett (1994) 0.93
Astroglial changes in the cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation. Neuropathol Appl Neurobiol (1993) 0.92
HIV replicates in cultured human brain cells. AIDS (1987) 0.90
The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells. J Neuroimmunol (1995) 0.87
Fate of oligodendrocytes in HIV-1 infection. AIDS (1991) 0.87
Central nervous system pathology in pediatric AIDS: an autopsy study. APMIS Suppl (1989) 0.87
Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev Neurosci (1994) 0.86
HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells. Biochem Biophys Res Commun (1993) 0.85
HIV receptors within the brain: a study of CD4 and MHC-II on human neurons, astrocytes and microglial cells. Res Virol (1991) 0.85
The role of nitric oxide in glial pathology. Ann N Y Acad Sci (1994) 0.78
Detection of human immunodeficiency virus DNA in cultured human glial cells by means of the polymerase chain reaction. Acta Neurol Scand (1991) 0.77
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science (1987) 12.77
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (1990) 9.72
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 8.73
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science (2001) 6.84
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Invariant visual representation by single neurons in the human brain. Nature (2005) 6.41
Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev (1997) 5.65
Guidelines for the management of hemophilia. Haemophilia (2012) 5.16
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
EFFECT OF IODINE ON THE THYROID GLAND IN GRAVES' DISEASE WHEN GIVEN IN CONJUNCTION WITH THIOURACIL-A TWO-ACTION THEORY OF IODINE. J Clin Invest (1945) 4.27
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci (2000) 4.14
Membrane pores induced by magainin. Biochemistry (1996) 3.97
Hippocampal and entorhinal cortex high-frequency oscillations (100--500 Hz) in human epileptic brain and in kainic acid--treated rats with chronic seizures. Epilepsia (1999) 3.96
High-frequency oscillations in human brain. Hippocampus (1999) 3.89
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity (2001) 3.43
The SCID-hu mouse as a model for HIV-1 infection. Nature (1993) 3.43
Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis (1992) 3.27
Category-specific visual responses of single neurons in the human medial temporal lobe. Nat Neurosci (2000) 3.21
Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol (1998) 3.09
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet (1994) 3.05
Membrane thinning caused by magainin 2. Biochemistry (1995) 3.03
High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science (1989) 3.00
Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J Virol (1993) 2.96
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet (1996) 2.93
Generation of HIV latency during thymopoiesis. Nat Med (2001) 2.91
Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med (1989) 2.81
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med (1998) 2.80
Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol (2001) 2.79
Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron (1991) 2.78
Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol (1994) 2.45
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol (1994) 2.36
Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol (1997) 2.35
Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest (1992) 2.28
Multiple shunt failures: an analysis of relevant factors. Childs Nerv Syst (1998) 2.25
A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25
X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytanoyl phosphatidylcholine with alamethicin at low concentrations. Biophys J (1995) 2.24
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation. J Virol (1990) 2.11
Generation of functional thymocytes in the human adult. Immunity (1999) 2.10
Ultra-fine frequency tuning revealed in single neurons of human auditory cortex. Nature (2008) 2.10
Inter-neonatal intensive care unit variation in discharge timing: influence of apnea and feeding management. Pediatrics (2001) 1.98
Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes. J Virol (1999) 1.97
Imagery neurons in the human brain. Nature (2000) 1.95
The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia (2004) 1.92
Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol (1998) 1.90
CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J Virol (1997) 1.88
Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J Immunol (1986) 1.87
Why do patients default from follow-up at a genitourinary clinic?: a multivariate analysis. Genitourin Med (1995) 1.86
Cooperative membrane insertion of magainin correlated with its cytolytic activity. Biochim Biophys Acta (1994) 1.84
Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 1.84
Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J Virol (1996) 1.80
Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology (1999) 1.77
Sparse but not 'grandmother-cell' coding in the medial temporal lobe. Trends Cogn Sci (2008) 1.76
In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J Virol (1998) 1.73
Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med (2006) 1.72
Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur J Immunol (1991) 1.71
Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol (2002) 1.71
Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A (2001) 1.68
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol (1990) 1.64
Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis. Genes Immun (2006) 1.64
Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ (1999) 1.63
Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood (1995) 1.62
In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med (1997) 1.61
Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function. Curr Cancer Drug Targets (2010) 1.60
Role of TCR zeta chain in T cell development and selection. Science (1994) 1.59
FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology (2008) 1.59
Pick's disease. A clinical, computed tomographic, and histologic study with golgi impregnation observations. Arch Neurol (1982) 1.58
Taurocholate transport by rat liver sinusoidal membrane vesicles: evidence of sodium cotransport. Hepatology (1982) 1.57
A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials (2005) 1.57
Effect of a lipidic extract from lepidium meyenii on sexual behavior in mice and rats. Urology (2000) 1.56
Human single-neuron responses at the threshold of conscious recognition. Proc Natl Acad Sci U S A (2008) 1.56
Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity (1997) 1.56
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys (2001) 1.53
Rat liver canalicular membrane vesicles. Isolation and topological characterization. J Biol Chem (1983) 1.51
Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J Virol (1990) 1.48
Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc Natl Acad Sci U S A (1999) 1.46
Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest (1993) 1.45
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos (1997) 1.43
Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J Virol (1998) 1.41
Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost (1997) 1.41
Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience (1994) 1.36
The role of nitric oxide in multiple sclerosis. J Mol Med (Berl) (1997) 1.36
Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood (1994) 1.33
Linkage of body mass index to chromosome 20 in Utah pedigrees. Hum Genet (2001) 1.32
An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. Br J Haematol (2005) 1.28
Effect of changing the size of lipid headgroup on peptide insertion into membranes. Biophys J (1997) 1.28
Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol (1997) 1.28
Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet (2001) 1.28
The mortality experience of workers exposed to tetrachlorodibenzodioxin in a trichlorophenol process accident. J Occup Med (1980) 1.27
Outreach STD clinics for prostitutes in Edinburgh. Int J STD AIDS (1995) 1.25
Taurocholate transport by rat liver canalicular membrane vesicles. Evidence for the presence of an Na+-independent transport system. J Clin Invest (1984) 1.24
Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection. J Virol (1997) 1.24
In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. J Virol (1995) 1.24
Complementary practitioners as part of the primary health care team: evaluation of one model. Br J Gen Pract (1995) 1.23
Decoding visual inputs from multiple neurons in the human temporal lobe. J Neurophysiol (2007) 1.22
Detection of cell cycle subcompartments by flow cytometric estimation of DNA-RNA content in combination with dual-color immunofluorescence. Cytometry (2000) 1.22